Assessing Prevalence Of Beta Lactamase Production From Clinical Isolates Of Hospitalized Patients And Comparison Of Antibiotic Susceptibility Patterns (EGAST 2008)

Pfizer

Status: Completed

Conditions: Infection

Study type: Observational

Funder types: Industry

Identifiers

NCT00728624

A1891005

Details and patient eligibility

About

EGAST 2008 is a prospective, non interventional, multicentric study (approximately 2000 isolates from 15- 20 sites).

Objectives:

• Comparison of antimicrobial susceptibility using disc-diffusion method
• Assessing prevalence of beta-lactamase producing strains among clinical isolates obtained from hospital in-patients

Full description

n/a n/a

Enrollment: 2,039 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Isolates (as specified in the observational plan) from hospitalised patients

Exclusion criteria

Isolates obtained from outpatients will not be included for the study. Isolates from repeat cultures performed during in-patient follow-up that were previously recruited into the study will be excluded.

Isolates identified as commensals or contaminants will be excluded